| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |